Source: International Congress 2018 – Respiratory muscles and lung function: from healthy subjects to patients
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Buhr (Los Angeles, CA, United States of America), I. Barjaktarevic (Los Angeles, CA, United States of America), X. Wang (Los Angeles, CA, United States of America), B. Dolezal (Los Angeles, CA, United States of America), M. Flynn (Los Angeles, CA, United States of America), D. Couper (Chapel Hill, NC, United States of America), W. Anderson (Chapel Hill, NC, United States of America), R. Paine (Salt Lake City, UT, United States of America), R. Kaner (New York, NY, United States of America), J. Curtis (Ann Arbor, MI, United States of America), W. O'Neal (Chapel Hill, NC, United States of America), P. Woodruff (San Francisco, CA, United States of America), L. Postow (Bethesda, MD, United States of America), M. Han (Ann Arbor, MI, United States of America), F. Martinez (New York, NY, United States of America), G. Barr (New York, NY, United States of America), J. Wells (Birmingham, AL, United States of America), V. Ortega (Winston-Salem, NC, United States of America), E. Hoffman (Iowa City, IA, United States of America), C. Doerschuk (Chapel Hill, NC, United States of America), V. Kim (Philadelphia, PA, United States of America), M. Dransfield (Birmingham, AL, United States of America), S. Bhatt (Birmingham, AL, United States of America), N. Bhakta (San Francisco, CA, United States of America), B. Drummond (Chapel Hill, NC, United States of America), R. Bowler (Denver, CO, United States of America), G. Criner (Philadelphia, PA, United States of America), C. Martinez (Ann Arbor, MI, United States of America), C. Cooper (Los Angeles, CA, United States of America), R. Kanner (Salt Lake City, UT, United States of America). Airflow obstruction which corrects post-bronchodilator as a predictor of future development of COPD. 2153

Member's Comments

No comment yet.

Related content which might interest you: Using the pre-bronchodilator spirometry curvature to improve estimation of post-bronchodilator airflow obstruction Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019 FEV6 as an alternative for FVC in predicting airway obstruction Source: Eur Respir J 2006; 28: Suppl. 50, 220s Year: 2006 Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007 Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016 Posture-induced changes in vital capacity are associated with COPD outcomes independent of airflow obstruction in SPIROMICS Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 FEV6 as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013 Forced inspiratory volume in one second (FIV1) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002 Expiratory airflow limitation and airways obstruction in COPD: Different patterns of the same disease? Source: Annual Congress 2010 - Airways and lung mechanics in subjects of all ages Year: 2010 What defines airflow obstruction in asthma? Source: Eur Respir J 2009; 34: 568 Year: 2009 Predictions of post-bronchodilator airflow obstruction by longitudinal asthma and wheeze patterns in middle-age Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021 Airway obstruction reversibility test in the assessment of COPD severity Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005 Factors predicting airflow obstruction in severe asthmatics Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 The use of forced oscillation technique (FOT) in assessment of airway obstruction and airtrapping in elderly COPD patients Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Auscultatory forced expiratory time as a predictor of FEV1 and as a clinical test of airway obstruction Source: Eur Respir J 2004; 24: Suppl. 48, 225s Year: 2004 The effect of pulmonary rehabilitation toward expiratory airflow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 FEV1 and MRI ventilation defect reversibility in asthma and COPD Source: Eur Respir J, 55 (3) 1901947; 10.1183/13993003.01947-2019 Year: 2020 Staging COPD by airflow obstruction underestimates the disease severity Source: Eur Respir J 2001; 18: Suppl. 33, 174s Year: 2001 FEV1/FEV6 versus FEV1/FVC in the spirometric detection of airway obstruction among Asians Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007